DOPAMINE D3 RECEPTOR LIGANDS FOR TREATMENT OF SUBSTANCE ABUSE

用于治疗药物滥用的多巴胺 D3 受体配体

• 批准号: 7958344
• 负责人: ROGER D SPEALMAN
• 金额: $ 1.27万
• 依托单位: HARVARD MEDICAL SCHOOL
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-05-01 至 2010-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7958344
• 关键词: Agonist; Behavioral; Computer Retrieval of Information on Scientific Projects Database; Disease; Funding; Grant; Institution; Ligands; Molecular; New England; Primates; Research; Research Personnel; Resources; Source; Substance abuse problem; United States National Institutes of Health; base; dopamine D3 receptor

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This project investigates at the molecular through behavioral levels the utility of dopamine D3 receptor antagonists and partial agonists for the treatment of substance abuse disorders.

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 本项目通过行为水平在分子水平上研究多巴胺D3受体拮抗剂和部分激动剂用于治疗物质滥用障碍的效用。